BIO Web Conf.
Volume 14, 2019The 12th International Conference on the Health Effects of Incorporated Radionuclides (HEIR 2018)
|Number of page(s)||2|
|Section||Biological Effects, Biochemistry, Molecular Biology: Oral presentations|
|Published online||07 May 2019|
Using mRNA and small RNA gene expression changes in peripheral blood for easy detection of Ra-223 incorporation
Bundeswehr Institute of Radiobiology, Munich, Germany
2 University Medical Center of the Johannes Gutenberg University, Clinic and Polyclinic for Nuclear Medicine, Mainz, Germany
3 Department of Urology, Federal Armed Services Hospital Koblenz, Koblenz, Germany
4 Supervisory Center for Medical Radiation Protection, Bundeswehr Medical Service Headquarters, Koblenz, Germany
* Corresponding author: email@example.com
Key words: Radiation analysis / incorporation / gene expression changes / radiation biomarkers / small RNA / mRNA / transcriptome / prostate cancer / Radium-223
Radiation analytics is the established method for detection of incorporated alpha-emitting radionuclides. It is laborious and time consuming. We wondered whether changes in gene expression measured in the human peripheral blood after radionuclide incorporation might serve as an easier approach for detection of incorporated radionuclides in a radiological or nuclear scenario.
We received whole blood in PAXgene Blood RNA tubes from four patients suffering from multiple bone-metastatic, castration-resistant prostate cancer (without visceral or nodal involvement), who underwent treatment with the alpha emitting isotope radium-223 dichloride (Ra-223, Xofigo®). Patients received about 4 MBq per cycle and month and were treated for six months.
In a first step, we employed next generation sequencing (NGS) for a whole genome screening of the transcriptome (mRNAs) as well as the post-transcriptome including small RNAs (e.g. long non-coding RNAs, snoRNAs and miRNAs) in one patient at 8 different time points during 6 cycles of Ra-223-therapy. This allowed us to identify specific candidate RNAs which are associated with the increased dose cumulated over the treatment time.
In a second step, candidate mRNAs and small RNAs which appeared dose-dependently differentially up- or down-regulated (>2-fold, p<0.05) in the screening samples will be chosen for validation. This will be performed by using the remaining patient samples (n=3 patients, each with up to 4 points in time) and shifting to more sensitive and specific qRT-PCR platform at the same time.
We will present and discuss the results on radiation-induced gene expression changes in whole blood which might serve as a simplified diagnostic tool for identification of incorporated radionuclides (Ra-223) in future.
© The Authors, published by EDP Sciences, 2019
This is an open access article distributed under the terms of the Creative Commons Attribution License 4.0 (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.